Worldwide Growth in Stevia Products & Natural Sweeteners Leads to Acquisitions, New Patents and Multi-Million Dollar Purchase Orders

CORAL SPRINGS, Florida, May 27, 2015 /PRNewswire/ --

Globally Companies are becoming more entrenched into the stevia sweetener market implementing new advancements for applications as a no-calorie, high-intensity sweetener in packaged food and drinks. As regulatory approvals unlock opportunities, increased demand has stevia suppliers focus on how to improve stevia to taste better, easier to formulate with, more sustainable, and scalable to supply.  Companies in focus today are:  Sunwin Stevia International, Inc. (OTC: SUWN, "Sunwin Stevia"), Archer Daniels Midland Company (NYSE: ADM), Stevia Corp. (OTC: STEV), Stevia First Corp. (OTC: STVF) and Johnson & Johnson (NYSE: JNJ)

Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin Stevia"), one of the top global providers of high quality stevia extracts including Rebaudioside A 98 and Rebaudioside A 99, announced today that it has submitted a patent application for its enzyme-treated stevia products.  For years stevia usage has not been widely accepted as a natural sweetener, because it has a bitter, licorice-like aftertaste even with high-grade stevia such as Rebaudioside A 98 and Rebaudioside A 99. To resolve the issue, Sunwin Stevia has been working with scientists to develop enzyme-treated stevia for years. The enzyme-treated stevia product is obtained by addition of glucose to stevia extracts using α-glucosyltransferase. In addition, a special treat stevia seed is required to grow special stevia leaf for such advanced product.  This new method can effectively decrease or eliminate the bitter aftertaste of natural stevia.  Sunwin Stevia is the only company in the world that offers such advanced products on a commercial basis.

Read the two most recent SUWN Press Releases including news of $3.2Mil Purchase Order at http://www.financialnewsmedia.com/profiles/suwn.html

Sunwin announced yesterday that it has received a major purchase order of 40 metric tons enzyme-treated stevia products valued over US$3.2 million for the calendar year of 2015 by Wild Flavors, Inc.  Enzyme-treated stevia is the most advanced stevioside product in the world and is used in the food and beverage industries. Stevia is a natural sweetener; however, it has a bitter, licorice-like aftertaste. Enzyme treated stevia is obtained by addition of glucose to stevia extracts using α-glucosyltransferase. In addition, a special treat stevia seed is required to grow special stevia leaf for such advanced product.  This new method can effectively decrease or eliminate the bitter aftertaste of natural stevia.  Sunwin Stevia is the only company in the world that offers such advanced products on a commercial basis.

Archer Daniels Midland Company (NYSE: ADM) announced recently that it has reached an agreement to purchase Meiweiyuan Biotechnology Co., a privately held sweetener manufacturer near the city of Wuhan, in the central Chinese province of Hubei.  "This acquisition helps further expand our footprint in regions with growing demand for our products," said Chris Cuddy, president of ADM's Corn Processing business. "Last November, we were excited to begin production at our new sweetener facility in Tianjin, which is allowing us to serve major customers in the northern part of the country as well as Asian export markets. Now, we are expanding to better meet demand for starches and sweeteners from customers in central and western China. This is another example of how ADM is looking for-and seizing-great opportunities for profitable growth."

Archer Daniels Midland Co. announced its biggest acquisition ever back in 2014, saying it agreed to buy Swiss food-ingredients maker Wild Flavors GmbH for $3 billion and in May of this year, ADM became a 20% shareholder of Sunwin Stevia International, Inc as evidenced in this filing http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10245356

In other sweetener news and happenings:  Stevia Corp. (OTCQB: STEV), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, announced in April that biochemist and former MD Anderson Cancer Researcher Dennis Hill has accepted a position on Stevia Corp.'s newly formed Advisory Panel. Dennis Hill has distinguished himself as being one of the few people on record in the world that achieved complete remission of cancer solely through the use of cannabis without conventional cancer treatment such as radiation or chemotherapy.

Stevia First Corp. (OTCQB: STVF) , an agricultural biotechnology company based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry, is pleased to announce that it has successfully closed its previously announced financing with institutional investors. Stevia First Corp. entered into a definitive securities purchase agreement for investors to purchase at a price of $0.30 per share an aggregate of approximately $1.5 million of the Company's common stock in a private placement. In addition, the Company issued to the investors three series of warrants to purchase additional shares of common stock. The financing was received and closed on May 11, 2015, and the full details of the transaction are available in the Company's public filings on a Form 8-K.

PepsiCo (NYSE: PEP) the maker of Pepsi, Mountain Dew, and many other popular soft drinks, is changing the formula of one of its offerings for the first time in decades. The company said recently it will stop sweetening Diet Pepsi, Caffeine Free Diet Pepsi and Wild Cherry Diet Pepsi with aspartame, a controversial artificial sweetener. Beginning in August, the drinks will instead come sweetened with Sucralose, better known as Splenda, brand of Johnson & Johnson (NYSE: JNJ), and acesulfame potassium, which is often called Ace K and is currently used in Coke Zero.  Read the full article at http://www.chicagotribune.com/business/chi-pepsi-aspartame-bad-science-20150428-story.html

FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services.  If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details.  Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/.  Follow us on Facebook:  http://www.facebook.com/financialnewsmedia and Twitter:  http://twitter.com/FNMgroup. 

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNMG is NOT affiliated in any manner with any company mentioned herein.  FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNMG is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG has been compensated three thousand four hundred dollars for news coverage of the current press release issued by Sunwin Stevia International, Inc. by a non-affiliated third party.  FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:  FN Media Group, LLC
Contact email:  [email protected]
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC